Feng Chi Biotech Corp. engages in the provision of neonatal genetic disease testing, new born screening, life science and microbiological testing services. It focuses on colorectal cancer, lung cancer; scientific research genetic testing and development. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.